|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PARRIS N. GLENDENING, Governor Ch. 18
|
|
|
|
|
|
|
|
|
|
(Y) " STATEWIDE ACADEMIC HEALTH CENTER NETWORK GRANT" MEANS THE
GRANT THAT IS DISTRIBUTED UNDER § 13-1118 OF THIS SUBTITLE.
(Z) " STATEWIDE ACADEMIC HEALTH CENTER PUBLIC HEALTH GRANT" MEANS
A GRANT THAT IS DISTRIBUTED UNDER § 13-1115 OF THIS SUBTITLE.
(AA) " STATEWIDE ACADEMIC HEALTH CENTER TOBACCO-RELATED DISEASES
RESEARCH GRANT" MEANS A GRANT THAT IS DISTRIBUTED UNDER 13-1017 OF THIS
SUBTITLE.
(R) (X) (BB) "STATEWIDE PUBLIC HEALTH COMPONENT" MEANS THE
COMPONENT OF THE PROGRAM THAT IS ESTABLISHED UNDER § 13-1106 OF THIS
SUBTITLE.
(S) (Y) (CC) "SURVEILLANCE AND EVALUATION COMPONENT" MEANS THE
COMPONENT OF THE PROGRAM THAT IS ESTABLISHED UNDER § 13-1103 OF THIS
SUBTITLE.
(T) (Z) (DD) "TARGETED CANCER" MEANS A CANCER THAT IS IDENTIFIED BY
THE DEPARTMENT UNDER SUBSECTION (D) OF THIS SECTION § 13- 1102(D) OF THIS
SUBTITLE.
(AA) (EE) "TASK FORCE REPORT" MEANS THE REPORT ENTITLED "REPORT OF
THE GOVERNOR'S TASK FORCE TO CONQUER CANCER" THAT WAS ISSUED IN
DECEMBER 1999.
(FF) " TOBACCO-RELATED DISEASES" MEANS CARDIOVASCULAR DISEASE.
CHRONIC PULMONARY DISEASE. PERIPHERAL VASCULAR DISEASE, STROKE, AND
INFANT MORTALITY DUE TO LOW BIRTH WEIGHT.
(BB) (GG) "TREATMENT" INCLUDES APPROPRIATE ACCESS TO:
(1) LOCAL HOSPITALS, COMMUNITY CLINICS, PHYSICIANS, AND OTHER
HEALTH CARE PROVIDERS; AND
(2) CLINICAL TRIALS, TRANSPORTATION, CASE MANAGEMENT, HOSPICE
CARE, AND CANCER SUPPORT GROUPS.
(CC) (HH) "UNINSURED INDIVIDUAL" MEANS AN INDIVIDUAL:
(1) FOR WHOM THE APPROPRIATE TREATMENT IS NOT COVERED BY
PRIVATE HEALTH INSURANCE, MEDICAID, OR MEDICARE, OR THE MARYLAND
CHILDREN'S HEALTH PROGRAM; AND
(2) WHO THE DEPARTMENT DETERMINES DOES NOT HAVE THE
FINANCIAL MEANS TO PAY FOR APPROPRIATE TREATMENT.
(U) (DD) (II) "UNIVERSITY OF MARYLAND MEDICAL SYSTEM GROUP"
MEANS THE UNIVERSITY OF MARYLAND MEDICAL SYSTEM CORPORATION, THE
UNIVERSITY OF MARYLAND MEDICAL SCHOOL, AND THE UNIVERSITY OF MARYLAND,
BALTIMORE.
|
|
|
|
|
|
|
|
|
|
- 317 -
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
